MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J15 · Effective Apr 17, 2022
11 active Medicare policies list 87626, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
National · Effective Aug 6, 2026
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 87626 |
|---|---|---|
| Nucleic Acid Pathogen Testing | Aug 15, 2026 | Covered |
| Preventive Care Services | Sep 1, 2026 | Covered |
| Policy | Effective | Status of 87626 |
|---|---|---|
| Cervical Cancer Screening Using Cytology and Human Papillomavirus Detection | Mar 5, 2026 | Covered |
National · Effective Aug 6, 2026
National · Effective May 14, 2026